polysaccharid
predominantli
obtain
variou
part
plant
alga
even
anim
crab
prawn
experienc
increas
use
pharmaceut
cosmet
industri
clear
advantag
synthet
polym
includ
econom
benefit
safeti
eas
chemic
modif
polysaccharid
chemic
modifi
improv
physicochem
mechan
properti
li
et
al
previou
decad
marinederiv
polysaccharid
receiv
attent
potenti
new
class
biomateri
polysaccharid
extract
marin
organ
minim
cost
comparison
plant
owe
abund
marin
organ
ocean
cardoso
et
al
manivasagan
oh
ruocco
et
al
advanc
biotechnolog
also
led
vitro
product
variou
marin
polysaccharid
product
yield
greatli
improv
optim
growth
condit
laurienzo
addit
marin
polysaccharid
gener
consid
biocompat
littl
toxic
particular
fucoidan
carrageenan
algin
chitosan
attract
enorm
attent
pharmaceut
biomed
industri
owe
physicochem
biolog
properti
venkatesan
et
al
marin
polysaccharid
extens
studi
therapeut
agent
treatment
variou
diseas
exampl
fucoidan
extract
sever
speci
brown
alga
shown
promis
therapeut
efficaci
includ
anticanc
antiinflammatori
activ
present
tabl
fitton
et
al
carrageenan
obtain
red
alga
show
antivir
activ
variou
type
virus
wang
et
al
addit
algin
extract
brown
alga
chitosan
obtain
marin
crustacean
explor
treatment
hypertens
fungal
diseas
marin
polysaccharid
also
wide
appli
field
biomed
engin
owe
tissu
regen
properti
observ
process
wound
heal
ayala
et
al
materi
use
improv
stabil
sensit
biosensor
use
tightli
affix
biomolecul
enzym
antibodi
reason
variou
biomed
system
util
marin
polysaccharid
current
studi
use
tissu
engin
applic
marin
polysaccharid
also
known
respond
extern
stimuli
includ
ph
temperatur
presenc
electr
field
tabl
order
widen
applic
marinederiv
polysaccharid
understand
function
marinederiv
polysaccharid
pharmaceut
biomed
industri
crucial
thu
review
comprehens
discuss
therapeut
activ
biomed
applic
marin
polysaccharid
particular
focu
fucoidan
carrageenan
algin
chitosan
cancer
group
diseas
caus
outofcontrol
cell
growth
although
exact
caus
cancer
remain
unknown
one
main
mechan
may
occurr
mutat
normal
gene
tumor
suppressor
gene
ozaki
nakagawara
common
treatment
cancer
includ
surgeri
chemotherapi
radiat
therapi
howev
main
limit
therapi
sever
damag
caus
normal
cell
high
prolif
index
gastrointestin
tract
bone
marrow
edri
thu
marin
polysaccharid
variou
anticanc
activ
attract
enorm
attent
potenti
altern
treatment
xue
et
al
particular
fucoidan
marin
polysaccharid
deriv
brown
seawe
demonstr
promis
anticanc
activ
variou
therapeut
mechan
patel
one
major
anticanc
mechan
exhibit
fucoidan
inhibit
angiogenesi
tumor
tissu
downregul
vascular
endotheli
growth
factor
vegf
teng
et
al
vegf
activ
vasculogenesi
angiogenesi
respons
hypoxia
uniqu
featur
local
advanc
solid
tumor
lin
et
al
vaupel
mayer
vegf
gene
one
gene
activ
hypoxiainduc
alpha
transcript
factor
control
erk
pathway
critic
pathway
growth
prolifer
tumor
cell
research
show
fucoidan
significantli
inhibit
phosphoryl
cascad
hypoxiainduc
mous
hepatocarcinoma
hcaf
cell
therebi
success
downregul
vegf
express
angiogenesi
tumor
tissu
huang
et
al
also
demonstr
antivegf
effect
fucoidan
could
also
inhibit
lung
carcinoma
metastas
vegf
abl
regul
vessel
permeabl
thu
promot
tumor
metastasi
shinkaruk
et
al
matrix
metalloproteinas
mmp
involv
integr
membran
disrupt
mmp
lead
tumor
invas
find
indic
fucoidan
downregul
vegf
mmp
express
lewi
lung
carcinoma
llc
inocul
model
mice
result
inhibit
cancer
metastasi
koyanagi
et
al
also
report
antiangiogen
activ
fucoidan
llc
melanoma
mice
therefor
demonstr
fucoidan
might
prevent
bind
vegf
vascular
endotheli
growth
factor
receptor
cell
downregul
signal
transduct
altern
anticanc
mechan
fucoidan
found
induct
apoptosi
antiapoptot
protein
survivin
known
play
pivot
role
regul
apoptosi
accord
xue
et
al
fucoidan
induc
proapoptot
effect
mous
breast
cancer
cell
decreas
express
fucoidan
also
decreas
express
survivin
smallest
member
inhibitor
apoptosi
protein
famili
addit
fucoidan
capabl
induc
releas
cytochrom
c
mitochondria
cytosol
subsequ
activ
caspas
cascad
ultim
lead
tumor
cell
apoptosi
fig
studi
conduct
hsu
et
al
fucoidan
exert
anticanc
activ
downregul
transform
growth
factor
receptor
ii
tgfri
tgfrii
report
induc
tumor
growth
overexpress
treatment
fucoidan
enhanc
ubiquitin
result
degrad
tgfr
vivo
experiment
result
support
fucoidaninduc
mark
reduct
tumor
volum
male
mice
xenograft
cell
fucoidan
also
reduc
viabil
variou
lung
cancer
cell
human
nonsmal
cell
lung
cancer
cell
mous
lung
cancer
cell
studi
shown
fucoidan
exert
varieti
indirect
anticanc
activ
potenti
adjuv
upregul
immun
respons
enhanc
endur
patient
receiv
prolong
chemotherapi
jin
et
al
report
fucoidan
use
adjuv
promot
helper
cell
cytotox
cell
tc
cell
immun
respons
ovalbumin
ova
antigen
intraperiton
inject
ova
fucoidan
show
enhanc
product
ovaspecif
antibodi
cell
respons
mice
moreov
express
level
major
histocompat
complex
class
ii
protein
upregul
inject
fucoidan
therefor
clear
fucoidan
function
potenti
adjuv
furthermor
notabl
function
may
contribut
develop
tumor
vaccin
ikeguchi
et
al
observ
fucoidan
exert
promis
protect
effect
toxic
chemotherapeut
drug
patient
unresect
advanc
recurr
colorect
cancer
trial
patient
unresect
advanc
recurr
colorect
cancer
patient
previous
administ
anticanc
drug
oxaliplatin
plu
irinotecan
plu
particip
random
two
differ
group
fucoidantr
group
n
untreat
control
group
n
observ
fucoidantr
group
endur
prolong
chemotherapi
without
gener
fatigu
advers
effect
result
demonstr
fucoidan
might
exert
anticanc
effect
precis
mechan
effect
remain
unverifi
associ
inflamm
sever
chronic
diseas
indubit
reason
regul
inflamm
highli
import
gener
inflamm
treat
variou
medic
nonsteroid
antiinflammatori
drug
nsaid
steroid
topic
steroid
oldest
frequent
use
treatment
local
inflamm
howev
prolong
use
steroid
may
caus
seriou
side
effect
includ
epitherm
thin
easi
bruis
perior
dermat
skin
atrophi
coondoo
et
al
thu
numer
research
sought
natur
product
exhibit
antiinflammatori
respons
without
sever
side
effect
among
natur
materi
investig
antiinflammatori
activ
fucoidan
result
widespread
use
treatment
inflammationassoci
diseas
tsubura
et
al
modul
local
inflamm
topic
treatment
fucoidan
experi
two
japanes
women
persist
pain
recurr
aphthou
stomat
ra
appli
fucoidancontain
cream
lesion
twice
per
day
week
side
effect
seen
patient
symptom
significantli
improv
followup
month
subsequ
research
conduct
similar
experi
chewabl
tablet
contain
fucos
treat
adult
patient
pain
symptomat
inflammatori
tongu
sit
tablet
prescrib
patient
unrespons
topic
corticosteroid
ointment
nsaid
chew
tablet
patient
experi
sting
symptom
remark
increas
heal
rate
observ
result
may
attribut
remodel
repair
process
exert
antiinflammatori
effect
fucoidan
tsubura
et
al
research
suggest
fucoidan
exert
antiinflammatori
activ
inhibit
variou
enzym
mmp
hyaluronidas
elastas
fucoidan
also
use
treatment
atop
dermat
ad
owe
abil
downregul
express
adassoci
cytokin
chemokin
yang
observ
fucoidan
reliev
adlik
symptom
dncb
treat
ncnga
mice
fucoidan
dexamethason
exhibit
similar
activ
strong
antiinflammatori
effect
comparison
control
group
fucoidantr
group
serum
level
inflammatori
factor
interleukin
il
histamin
consider
reduc
therebi
prevent
mast
cell
infiltr
immunoglobulin
e
secret
lesion
site
therefor
fucoidan
could
use
potenti
therapeut
treatment
ad
symptom
prefer
exist
corticosteroid
drug
studi
shown
fucoidan
abl
prevent
inflammatori
damag
ischem
event
action
blocker
selectin
protein
recruit
leukocyt
inflammatori
lesion
koch
et
al
ritter
et
al
cumashi
et
al
myer
et
al
perform
open
label
studi
particip
osteoarthr
knee
particip
randomli
assign
group
treat
differ
dose
fucoidan
approxim
week
consumpt
formul
fucoidan
result
dosedepend
decreas
comprehens
arthriti
test
subscal
pain
stiff
physic
difficulti
overal
symptom
sever
author
suggest
selectinblock
activ
fucoidan
may
reduc
leukocyt
accumul
arthrit
region
therefor
markedli
improv
inflammatori
symptom
anoth
studi
investig
immunomodulatori
effect
fucoidan
connor
et
al
conduct
openlabel
studi
use
fucoidan
immun
modul
healthi
particip
n
randomli
assign
receiv
differ
dose
fucoidan
period
oral
administr
fucoidan
increas
number
tc
cell
phagocyt
capac
monocyt
fucoidan
also
decreas
one
major
inflammatori
cytokin
thu
result
also
support
use
fucoidan
potenti
antiinflammatori
drug
virus
submicroscop
infect
agent
consist
nucleic
acid
core
protein
coat
requir
live
host
cell
replic
orlova
pathogen
virus
infect
human
cell
may
caus
varieti
symptom
mild
diseas
common
cold
flu
chronic
diseas
infect
human
papillomaviru
hpv
therefor
numer
type
antivir
medicin
develop
treat
infect
caus
virus
recent
marin
polysaccharid
receiv
attent
antivir
effect
ghosh
et
al
specif
antivir
properti
carrageenan
shown
promis
inhibitori
effect
mani
type
virus
leibbrandt
et
al
exploit
antivir
activ
carrageenan
influenza
viru
carrageenan
treatment
result
increas
surviv
rate
influenza
virusinfect
cell
vitro
author
discuss
result
obtain
carrageenan
effect
block
intern
viru
disrupt
interact
host
cell
receptor
direct
bind
viru
particl
addit
inhibit
neuraminidas
essenti
glycoprotein
releas
viru
host
cell
also
support
result
buck
et
al
talarico
damont
consensu
vitro
result
vivo
test
also
indic
intranas
applic
carrageenan
markedli
increas
surviv
rate
mice
infect
influenza
viru
result
similar
obtain
oseltamivir
brand
name
tamiflu
commerci
neuraminidas
inhibitor
therefor
author
suggest
carrageenan
could
use
potent
antivir
agent
may
replac
market
drug
elucid
effect
carrageenan
nasal
spray
koenighof
et
al
conduct
two
doubleblind
random
control
trial
patient
common
cold
infect
human
rhinoviru
human
coronaviru
influenza
viru
patient
receiv
carrageenan
nasal
spray
experienc
fewer
relaps
symptom
increas
viral
clearanc
trial
compar
placebo
group
find
therefor
demonstr
clinic
effect
carrageenan
antivir
agent
three
viru
subgroup
et
al
show
carrageenan
could
also
inhibit
hpv
author
investig
vitro
vivo
antivir
activ
carrageenan
hela
cell
mous
hpv
pseudoviru
psv
model
respect
gel
formul
differ
amount
carrageenan
wv
use
vitro
vivo
test
formul
show
nontox
antivir
properti
three
type
hpv
vitro
hpv
also
intravagin
administr
carrageenanbas
gel
balbc
mice
result
signific
protect
psv
infect
antivir
activ
carrageenan
gel
show
dosedepend
activ
vivo
effect
might
relat
properti
carrageenan
block
adhes
viru
heparan
sulfat
express
cell
surfac
play
key
role
viral
entri
infect
shukla
spear
zhu
et
al
algin
disrupt
mucinmucin
interact
chelat
calcium
ion
ambort
et
al
util
reduc
accumul
intestin
mucu
mice
cystic
fibrosi
cf
vitko
et
al
evalu
therapeut
effect
algin
oligosaccharid
oligog
cf
mous
model
cf
caus
mutat
gene
encod
cf
transmembran
conduct
regul
protein
lead
intestin
damag
accumul
gluelik
thick
mucu
within
duct
tube
bodi
cf
mice
oligog
solut
enhanc
intestin
transit
time
effect
caus
intestin
content
move
small
intestin
result
higher
surviv
rate
regular
water
result
demonstr
algin
oligom
oligog
may
play
key
role
decreas
mucu
accumul
disrupt
mucin
crosslink
calcium
sequestr
taylor
draget
sletmoen
et
al
pritchard
et
al
algin
also
show
potent
prevent
effect
hypertens
hypertens
may
result
sever
caus
excess
sodium
intak
hypokalemia
madia
treatment
hypertens
import
reduc
sodium
retent
increas
potassium
concentr
chen
et
al
investig
antihypertens
effect
low
molecular
mass
potassium
algin
lpa
kcl
hypertens
rat
induc
deoxycorticosteron
acet
doca
salt
oral
administr
day
lpa
significantli
prevent
develop
hypertens
mortal
dosedepend
manner
lpa
also
inhibit
cardiac
renal
hypertrophi
deriv
hypokalemia
revers
hypertens
hypokalemia
doca
saltinduc
hypertens
rat
antihypertens
effect
much
greater
kcl
find
could
explain
mechanist
lpa
might
provid
greater
cellular
exchang
sodium
kcl
directli
regul
vasoconstrict
sodium
resorpt
renal
tubul
myriad
therapeut
effect
make
algin
excel
candid
develop
potenti
promis
therapi
variou
diseas
one
studi
indic
chitosan
show
potent
antifung
activ
candida
strain
caus
superfici
mycos
includ
vulvovagin
candidiasi
although
exact
antifung
mechan
chitosan
clearli
identifi
like
result
disrupt
membran
stabil
bind
posit
charg
chitosan
neg
charg
cell
wall
fungu
fig
alburquenqu
et
al
explor
possibl
antifung
properti
low
molecular
weight
chitosan
lmwc
clinic
isol
candida
speci
vitro
treatment
lmwc
show
signific
inhibit
strain
improv
antifung
activ
ph
suggest
chitosan
strong
antifung
properti
addit
report
suggest
toxic
chitosan
might
much
less
like
occur
human
park
et
al
vinsova
vavrikova
final
medic
contain
chitosan
exert
appreci
low
toxic
mark
antifung
effect
could
potenti
exploit
treatment
candidiasi
gener
emerg
environ
ph
damag
tissu
result
sever
health
problem
human
reason
scientist
continu
attempt
regener
damag
tissu
variou
strategi
use
platform
contain
therapeut
cell
stem
cell
tissu
regener
agent
order
confer
multifunction
biocompat
platform
identif
suitabl
fundament
materi
fabric
platform
highli
crucial
among
materi
investig
purpos
marin
polysaccharid
algin
fucoidan
carrageenan
shown
promis
owe
gel
format
abil
mild
condit
gutowska
et
al
ayala
et
al
biocompat
lee
mooney
biocompat
noncytotox
properti
martin
et
al
marin
polysaccharid
process
scaffold
tissu
engin
cancer
therapi
stephan
et
al
park
et
al
carrier
variou
tissueregener
agent
growth
factor
dna
mrna
product
protein
contribut
tissu
repair
algin
use
prepar
scaffold
bone
tissu
engin
intrins
biocompat
low
toxic
alsberg
et
al
lee
et
al
mannuron
acidguluron
acid
ratio
algin
shown
highli
affect
biocompat
algin
et
al
demonstr
algin
mannuron
acid
elicit
inflammatori
respons
implant
rat
mushollaeni
et
al
observ
low
toxic
algin
extract
variou
seawe
sargassum
padina
mice
result
indic
mani
differ
kind
algin
exhibit
signific
toxicolog
effect
although
one
limit
algin
degrad
human
bodi
howev
algin
oxid
confer
biodegrad
strategi
use
tissu
engin
applic
gao
et
al
moshaverinia
et
al
compar
degrad
algin
hydrogel
differ
oxid
level
pb
observ
oxid
rate
algin
hydrogel
proport
degrad
rate
polysaccharid
carrageenan
use
fabric
carrier
deliveri
tissu
regener
agent
marin
polysaccharid
proven
exhibit
good
biocompat
nontox
cohen
ito
rocha
et
al
eccl
et
al
evalu
efficaci
safeti
carrageenan
human
volunt
carrageenantr
group
carrageenan
reduc
level
proinflammatori
mediat
fibroblast
growth
il
similar
result
also
report
mckim
et
al
evalu
cytotox
carrageenan
human
intestin
hepat
cell
line
result
show
carrageenan
induc
proinflammatori
factor
monocyt
chemoattract
human
intestin
hepat
cell
studi
demonstr
biocompat
safeti
nontox
carrageenan
moreov
gelform
abil
carrageenan
exploit
control
releas
cargo
carrageenan
hydrogel
contain
plateletderiv
growth
factor
pdgf
bone
tissu
regener
properti
promot
angiogenesi
battegay
et
al
investig
santo
et
al
research
group
evalu
encapsul
efficaci
releas
rate
pdgf
incorpor
carrageenan
hydrogel
observ
sustain
releas
pdgf
carrageenan
hydrogel
result
crosslink
hydrogel
k
ion
format
ionic
bond
sulfat
group
cation
carrageenan
process
enhanc
mechan
strength
hydrogel
might
crucial
factor
sustain
releas
pdgf
furthermor
encapsul
effici
pdgf
carrageenan
hydrogel
control
crosslink
time
carrageenan
k
ion
addit
fucoidan
assist
tissu
regener
process
modul
physiolog
process
han
et
al
use
natur
antioxid
properti
fucoidan
protect
mesenchym
stem
cell
msc
ischemiainduc
apoptosi
group
suggest
fucoidan
promot
express
manganes
superoxid
dismutas
enhanc
surviv
msc
inhibit
gener
intracellular
reactiv
oxygen
speci
moreov
lowmolecularweight
lmw
fucoidan
report
increas
express
growth
factor
fgf
vascular
endotheli
growth
factor
chabut
et
al
lake
et
al
studi
lmw
fucoidan
promot
prolifer
human
osteoblast
increas
product
growth
factor
subsequ
promot
regener
bone
tissu
changotad
et
al
applic
possibl
fucoidan
caus
acut
subchron
toxic
li
et
al
demonstr
fucoidan
show
sign
toxic
oral
administr
rat
dose
mgkg
bodi
weight
per
day
fucoidan
show
signific
toxic
advers
effect
chung
et
al
also
report
low
toxic
fucoidan
variou
vitro
vivo
test
ame
test
mutagen
observ
fucoidantr
group
addit
fucoidan
induc
toxicolog
chang
rat
day
oral
administr
result
confirm
possibl
use
fucoidan
applic
tissu
engin
biosensor
diagnost
devic
detect
specif
biochem
gener
reaction
target
analyt
immobil
biomolecul
enzym
antibodi
receptor
electrod
compar
diagnost
tool
biosensor
offer
advantag
high
specif
fast
respons
time
user
conveni
portabl
exampl
patient
diabet
reliev
potenti
complic
heart
diseas
kidney
failur
blind
person
manag
blood
glucos
concentr
use
glucos
biosensor
wang
biosensor
gener
consist
biolog
element
react
target
analyt
transduc
transform
signal
result
reaction
biomolecul
measur
quantifi
valu
immobil
sens
element
electrod
therefor
crucial
design
effici
biosensor
immobil
process
biolog
element
requir
maintain
chemic
structur
react
analyt
remain
electrod
ensur
high
stabil
biosensor
reproduc
result
sassola
et
al
glucos
biosensor
typic
detect
product
reaction
immobil
enzym
gener
reaction
glucos
oxidas
gox
glucos
immobil
gox
oxid
glucos
produc
hydrogen
peroxid
hydrogen
peroxid
oxid
catalyst
palladium
platinum
anod
produc
electron
detect
produc
resultsdocumentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
text
glucos
text
gox
left
text
fad
right
text
glucolacton
text
gox
left
text
fadh
right
end
document
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
text
gox
left
text
fadh
right
text
text
gox
left
text
fad
right
text
h
text
end
document
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
text
h
text
text
text
text
end
document
biocompat
nontox
properti
algin
chitosan
kang
et
al
provid
biomolecul
suitabl
microenviron
reaction
moreov
hydrophil
properti
gelform
abil
polysaccharid
improv
stabil
immobil
biomolecul
ph
pka
chitosan
becom
deproton
solubl
subsequ
form
viscou
hydrogel
matrix
algin
owe
anion
properti
also
form
viscou
matrix
crosslink
dival
cation
acid
environ
properti
marin
polysaccharid
use
fix
biomolecul
maintain
activ
howev
marin
polysaccharid
exhibit
low
catalyt
activ
hydrogel
fabric
polysaccharid
electrocatalyst
investig
describ
moreov
copolym
marin
polym
conduct
polym
polypyrrol
polyanilin
polythiophen
improv
sensit
biosensor
fig
chitosan
matrix
improv
stabil
select
biosensor
provis
stabl
environ
oxid
catalyst
magnetit
kavitha
et
al
platinum
wu
et
al
palladium
zeng
et
al
prussian
blue
pb
redox
mediat
select
detect
hydrogen
peroxid
form
hybrid
film
chitosan
neutral
ph
weakli
alkalin
medium
pb
deposit
chitosan
film
show
improv
stabil
wang
et
al
algin
hydrogel
prepar
calcium
also
increas
respons
effici
biomolecul
increas
sensit
biosensor
han
et
al
acid
condit
posit
charg
chitosan
easili
adsorb
gold
nanoparticl
catalyt
properti
amino
group
form
amid
linkag
conduct
polym
polypyrrol
carboxyl
residu
algin
use
form
coval
bond
conduct
materi
n
pyrrol
lead
increas
conduct
improv
sensit
biosensor
aburabeah
mark
nanofib
prepar
chitosan
polyvinyl
alcohol
also
promot
enzymeanalyt
respons
owe
decreas
diffus
resist
substrat
high
surfac
area
matrix
su
et
al
chitosan
also
use
type
biosensor
similar
glucos
biosensor
cholesterol
biosensor
detect
hydrogen
peroxid
gener
oxid
reaction
cholesterol
oxidas
chitosanbas
film
appli
cholesterol
biosensor
improv
sensit
khan
et
al
safavi
farjami
addit
chitosan
film
warner
andreescu
nanocomposit
chitosan
pb
zhao
et
al
also
use
improv
pesticid
biosensor
thu
use
marin
polysaccharid
fundament
materi
variou
biosensor
demonstr
strong
potenti
improv
biosensor
function
surgic
implant
use
repair
replac
damag
organ
tissu
implant
includ
orthoped
implant
dental
implant
stent
despit
benefit
surgic
implant
frequent
occurr
infect
site
surgeri
limit
use
implant
resolv
problem
implant
surfac
coat
variou
materi
prevent
prolifer
bacteria
staphylococcu
aureu
jiri
et
al
inhibit
infect
bacteria
drugload
polym
also
use
coat
surfac
implant
shown
fig
noreen
irv
materi
use
surfac
coat
surgic
implant
includ
hydroxyapatit
ha
polymethylmethacryl
pmma
poli
lactic
acid
pla
poli
glycol
acid
pga
comparison
materi
mention
marin
polysaccharid
chitosan
algin
exhibit
high
bacteriostat
properti
addit
polysaccharid
exhibit
problem
relat
toxic
acid
degrad
product
gener
degrad
pla
pga
alex
et
al
vitro
toxic
test
also
demonstr
differ
molecular
weight
degre
deacetyl
chitosan
exhibit
low
cytotox
human
lymphoblast
leukemia
human
embryon
lung
cell
kean
thanou
addit
result
sever
test
acut
system
toxic
test
irrit
test
eye
skin
show
chitosan
caus
undesir
toxic
mice
rabbit
guinea
pig
rao
sharma
low
toxic
biocompat
eas
film
format
marin
polysaccharid
contribut
attract
polysaccharid
surfac
coat
surgic
implant
electrophoret
deposit
posit
charg
chitosan
use
fabric
film
contain
gentamicin
prevent
infect
implant
surfac
pishbin
et
al
aldehyd
group
titanium
form
silan
reaction
also
form
coval
bond
amin
group
chitosan
could
exploit
coat
titanium
surfac
implant
chitosan
bumgardn
et
al
caus
local
drug
deliveri
antimicrobi
drug
vancomycin
swanson
et
al
chitosan
posit
charg
pka
antibacteri
activ
polysaccharid
applic
acid
environ
overcom
limit
quatern
chitosan
qch
contain
posit
charg
quaternari
ammonium
group
use
increas
aqueou
solubl
antibacteri
activ
chitosan
antibacteri
activ
qch
wide
rang
ph
valu
success
use
orthoped
implant
wiarachai
et
al
honglu
et
al
algin
hydrogel
also
use
inhibit
infect
surgic
implant
research
group
prepar
ringshap
dental
implant
composit
hydrogel
algin
pcl
contain
metronidazol
variat
ratio
algin
pcl
mechan
properti
ring
implant
could
modifi
achiev
sustain
releas
metronidazol
lan
et
al
stent
tubular
meshstructur
medic
devic
commonli
use
recov
narrow
coronari
arteri
caus
atherosclerosi
howev
problem
plaqu
reoccurr
stent
known
instent
restenosi
movement
stent
site
known
migrat
limit
use
stent
resolv
problem
stent
modifi
variou
way
creat
selfexpand
biodegrad
drugelut
stent
mani
et
al
biodegrad
biocompat
adhes
properti
anticoagul
activ
chitosan
exploit
purpos
chitosan
also
use
fabric
selfexpand
stent
lauto
et
al
chitosan
stent
contact
moistur
target
tissu
selfexpand
perform
stent
function
anoth
studi
thiolat
chitosan
known
exert
mucoadhes
properti
format
disulfid
bond
mucin
layer
coat
onto
surfac
stent
zhao
et
al
stent
coat
thiolat
chitosan
show
enhanc
mucoadhes
therebi
prevent
unwant
migrat
stent
fucoidan
also
coat
onto
surfac
stent
prevent
restenosi
occur
growth
smooth
muscl
cell
smc
stent
kim
et
al
fucoidan
sulfat
polysaccharid
inhibit
prolifer
rat
smc
vitro
mechan
inhibitori
effect
fucoidan
restenosi
fulli
understood
may
occur
bind
fucoidan
growth
factor
affect
express
fibronectin
thrombospondin
therebi
inhibit
prolifer
smc
religa
et
al
periton
adhes
postop
diseas
experienc
approxim
patient
undergon
abdomin
surgeri
complic
includ
small
bowel
obstruct
femal
infertil
abdomin
pelvic
pain
influenc
patient
qualiti
life
burden
patient
huge
surgic
hospit
expens
ergul
korukluoglu
periton
adhes
caus
cytokin
coagul
factor
proteas
molecul
caus
inflamm
angiogenesi
tissu
repair
ultim
lead
periton
adhes
et
al
one
possibl
strategi
prevent
periton
adhes
applic
physic
barrier
inhibit
periton
adhes
damag
surfac
separ
damag
site
tissu
physic
barrier
gener
compos
natur
polym
gelatin
collagen
hyaluron
acid
chondroitin
sulfat
synthet
polym
silicon
poli
tetrafluoro
ethylen
poli
vinyl
alcohol
poli
hydroxyl
acid
polym
shown
effect
reduc
periton
adhes
howev
rapid
clearanc
barrier
appli
site
larg
problemat
may
requir
addit
sutur
process
cho
et
al
mucoadhes
properti
algin
chitosan
use
resolv
problem
ahuja
et
al
carboxyl
group
algin
form
hydrogen
bond
hydroxyl
group
adjac
tissu
protein
therefor
uncrosslink
algin
hydrogel
mani
free
carboxyl
group
crosslink
algin
gel
use
prepar
mucoadhes
antiadhes
film
cho
et
al
uncrosslink
hydrogel
also
transpar
flexibl
use
applic
injur
site
uncrosslink
algin
hydrogel
success
reduc
periton
adhes
n
ocarboxymethyl
chitosan
nocc
watersolubl
neg
charg
polym
although
mechan
antiperiton
adhes
nocc
fulli
elucid
yet
inhibitori
activ
nocc
periton
adhes
cardiac
surgeri
adhes
determin
zhu
zhang
inject
crosslink
nocchyaluron
acid
hydrogel
found
consider
reduc
format
periton
adhes
show
biocompat
biodegrad
li
et
al
progress
heart
failur
left
ventricl
lv
wall
thick
heart
gener
decreas
shape
lv
chang
ellips
sphere
deform
lv
caviti
lead
increas
lv
contract
volum
increas
lv
contract
volum
caus
increas
stress
lv
wall
follow
deterior
heart
failur
reason
increas
lv
wall
thick
decreas
lv
caviti
prevent
aggrav
heart
failur
clinic
studi
algin
hydrogel
found
possess
similar
structur
extracellular
matrix
ecm
lee
et
al
algin
hydrogel
inject
lv
wall
increas
thick
lv
wall
structur
restor
lv
wall
led
decreas
lv
caviti
mechan
stress
onto
lv
wall
decreas
mechan
stress
onto
lv
wall
improv
cardiac
function
landa
et
al
lee
et
al
ph
valu
variou
organ
tissu
human
bodi
differ
addit
tissu
associ
diseas
tumor
gener
acid
environ
thu
phrespons
drug
deliveri
system
select
releas
drug
target
tissu
exhibit
improv
drug
deliveri
effici
ph
carboxyl
group
algin
ioniz
polym
becom
solubl
therefor
drug
select
releas
algin
gel
respons
alkalin
environ
found
intestin
phsensit
algin
gel
also
protect
drug
labil
acid
environ
stomach
acid
therebi
increas
bioavail
drug
exampl
iliescu
et
al
use
ionotrop
gelat
process
formul
algin
nanoparticl
contain
irinotecan
colorect
tumor
tissu
nanoparticl
adher
mucos
membran
colorect
tumor
swell
releas
cargo
anoth
studi
use
phsensit
konjac
glucomannansodium
algin
hydrogel
perform
wang
et
al
contain
hydrogel
select
releas
alkalin
ph
environ
colorect
cancer
site
phrespons
properti
chitosan
confer
proton
amino
group
acid
ph
valu
also
exploit
phrespons
drug
deliveri
system
exampl
saboktakin
et
al
develop
supramolecular
chitosan
gel
deliveri
insulin
chitosan
gel
protect
insulin
acid
environ
stomach
releas
protein
intestin
sustain
manner
temperaturerespons
drug
deliveri
system
use
releas
drug
target
site
respons
bodi
temperatur
chitosan
carrageenan
use
purpos
owe
lack
temperaturedepend
respons
must
use
combin
temperaturerespons
materi
frequent
use
temperaturesensit
polym
poli
nisopropylacrylamid
pnipam
pnipam
exhibit
lower
critic
solut
temperatur
lcst
ambient
temperatur
becom
lower
lcst
hydrogen
bond
form
polym
chain
water
molecul
polym
dissolv
water
temperatur
increas
hydrogen
bond
collaps
polym
becom
insolubl
water
li
et
al
develop
thermosensit
hollow
sphere
use
selfassembl
properti
chitosangraftpnipam
csgpnipam
studi
chitosan
graft
pnipam
crosslink
sodium
tripolyphosph
ionic
crosslink
agent
pnipam
form
core
hollow
sphere
shell
compos
chitosan
load
inner
caviti
csgpnipam
hollow
sphere
temperatur
lcst
releas
csgpnipam
hollow
sphere
owe
destruct
interact
polym
drug
anoth
research
group
also
develop
thermosensit
chitosanbas
formul
weakli
basic
glycerophosph
gp
addit
gp
chitosan
solut
could
prevent
precipit
chitosan
high
ph
valu
owe
strong
electrostat
attract
phosphat
group
gp
ammonium
group
chitosan
temperatur
increas
strong
interact
decreas
dehydr
chitosan
chain
occur
transform
solut
gel
mechan
formul
gell
immedi
bodi
temperatur
revert
sol
statu
cool
process
thermosensit
gell
system
effici
deliv
doxepin
brain
via
intranas
rout
naik
nair
carrageenan
also
use
thermosensit
system
combin
thermosensit
polym
exampl
li
et
al
deliv
ketorolac
tromethamin
via
intranas
rout
use
thermosensit
gel
system
compos
carrageenan
poloxam
poloxamerbas
gel
lack
mucoadhes
critic
obstacl
especi
deliv
via
caviti
mucou
membran
carrageenan
exhibit
signific
bioadhes
properti
owe
hydrogen
bondform
group
incorpor
bioadhes
carrageenan
poloxam
gel
improv
mucos
deliveri
drug
control
drug
releas
achiev
electr
fieldrespons
drug
deliveri
system
releas
drug
regul
strength
current
voltag
electr
field
gener
electr
fieldsensit
system
contain
two
redox
state
one
allow
electrostat
interact
ionic
drug
electr
fieldrespons
releas
drug
commonli
accomplish
seri
reductionoxid
process
electr
field
control
electr
field
electrod
drug
releas
system
regul
marin
polysaccharid
chitosan
algin
use
fabric
electr
fieldrespons
drug
deliveri
system
owe
biocompat
biodegrad
electr
field
respons
provid
electr
conduct
materi
chandran
sandhyarani
develop
electr
fieldrespons
chitosangold
nanocomplex
control
deliveri
cervic
cancer
cell
studi
gold
nanoparticl
strong
electr
conduct
abil
integr
chitosan
matrix
embed
electrod
site
chitosangold
nanocomplex
besid
tumor
cell
applic
electr
field
drug
could
releas
control
manner
shi
et
al
develop
hybrid
hydrogel
compos
bacteri
cellulos
nanofib
sodium
algin
contain
ibuprofen
algin
numer
ioniz
carboxyl
group
algin
select
main
compon
hydrogel
applic
electr
stimulu
hydrogen
ion
move
algin
matrix
cathod
surfac
absenc
hydrogen
ion
result
ioniz
algin
lead
swell
hydrogel
drug
releas
therefor
drug
releas
could
control
regul
electr
stimulu
versatil
properti
marin
polysaccharid
extens
investig
pharmaceut
biomed
field
particular
fucoidan
carrageenan
algin
chitosan
demonstr
variou
therapeut
efficaci
anticanc
antiinflammatori
antivir
activ
exploit
fundament
support
materi
biomed
engin
pharmaceut
formul
owe
suitabl
physicochem
biolog
properti
effort
made
elucid
therapeut
efficaci
identifi
novel
role
marin
polysaccharid
illustr
possibl
polysaccharid
substitut
exist
therapeut
convent
synthet
polym
exhibit
undesir
side
effect
poor
biocompat
howev
major
challeng
remain
overcom
maxim
potenti
polysaccharid
although
mechan
therapeut
efficaci
marin
polysaccharid
gradual
elucid
poor
correl
among
vitro
vivo
clinic
investig
exhibit
studi
limit
clinic
translat
polysaccharid
differ
studi
differ
environ
may
predominantli
attribut
absenc
appropri
deliveri
system
effici
transport
therapeut
polysaccharid
desir
site
thu
futur
studi
focu
maxim
therapeut
potenti
marin
polysaccharid
design
novel
deliveri
system
highli
compat
polysaccharid
addit
precis
design
investig
therapeut
mechan
marin
polysaccharid
conduct
elucid
exact
biomolecular
featur
biochem
pathway
therapeut
action
polysaccharid
given
continu
effort
maxim
potenti
marin
polysaccharid
therapeut
fundament
materi
applic
biomed
engin
pharmaceut
industri
rang
applic
polysaccharid
broaden
provid
novel
advantag
achiev
exist
polym
